ID

20603

Beskrivning

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00630565

Länk

https://clinicaltrials.gov/show/NCT00630565

Nyckelord

Versioner (1)
  1. 2017-03-06 2017-03-06 -
Uppladdad den

6 mars 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Leukemia NCT00630565

Engelsk

Eligibility Leukemia NCT00630565

1 Formulär  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00630565
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
children under the age of two are eligible for this protocol, but will not receive total body irradiation. instead, children under the age of two will receive busulfan/cyclophosphamide (bu/cy) conditioning as the preparative regimen in order to obviate deleterious effects of radiation at this age. patients who cannot receive total body irradiation (tbi) (for example those with prior radiation therapy) will also receive the bu/cy conditioning.
Beskrivning

Child; Age | Whole-Body Irradiation | busulfan/cyclophosphamide; Preparative Regimen | prior radiation therapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0008059
UMLS CUI [1,2]
C0001779
UMLS CUI [2]
C0043162
UMLS CUI [3,1]
C0278611
UMLS CUI [3,2]
C1882454
UMLS CUI [4]
C0279134
acute myeloid leukemia (aml)
Beskrivning

aml

Datatyp

boolean

Alias
UMLS CUI [1]
C0023467
all children and adults less than the age of 70 with aml who have achieved a first or second bone marrow remission are eligible for this protocol. patients must undergo peripheral blood stem cell collection or marrow harvest while in remission and must not be expected to have better outcomes with allogeneic transplantation.
Beskrivning

Age | Leukemia, Myelocytic, Acute | Acute myeloid leukemia in remission; Bone Marrow | Harvesting of peripheral blood stem cells | Bone marrow harvesting for transplantation; autologous | Allogeneic bone marrow transplantation; Treatment outcome

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0023467
UMLS CUI [3,1]
C0153886
UMLS CUI [3,2]
C0005953
UMLS CUI [4]
C0457411
UMLS CUI [5]
C3248104
UMLS CUI [6,1]
C0149615
UMLS CUI [6,2]
C0085415
patients with cytogenetic abnormalities suggesting an improved prognosis [t(8:21), t(15;17) and inv(16)] will be eligible for transplantation in first remission.
Beskrivning

cytogenetic abnormalities suggesting an improved prognosis, remission

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1541330
UMLS CUI [1,2]
C1514475
UMLS CUI [2]
C0544452
UMLS CUI [3]
C1504389
allogeneic transplant with an hla-identical sibling will be recommended for patients <55 years. if the patient refuses allogeneic transplant, they may still be eligible for this protocol.
Beskrivning

Allogeneic bone marrow transplantation | Histocompatibility Testing; Allograft of bone marrow from sibling donor | Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0149615
UMLS CUI [2,1]
C0019633
UMLS CUI [2,2]
C1960320
UMLS CUI [3]
C0001779
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients can also be deemed not eligible for transplant because of specific organ toxicity. specifically, patients with pre-existing compromise to the heart, lungs, kidney, cns or liver may be excluded:
Beskrivning

Drug toxicity | Heart Diseases | Lung diseases | Kidney Diseases | Liver diseases | CNS disorder

Datatyp

boolean

Alias
UMLS CUI [1]
C0013221
UMLS CUI [2]
C0018799
UMLS CUI [3]
C0024115
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0023895
UMLS CUI [6]
C0007682
eastern cooperative oncology group (ecog) performance status: 0 or 1
Beskrivning

ecog

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
heart - the patient must be free of symptoms of uncontrolled cardiac disease, and must not have compromised cardiac function detected by echo or by gated cardiac blood flow scan (muga) lvef >45%).
Beskrivning

Heart Diseases | Left ventricular ejection fraction | Echocardiography | Multiple gated acquisition scanning

Datatyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0428772
UMLS CUI [3]
C0013516
UMLS CUI [4]
C0521317
kidney - the patient must have a corrected creatinine clearance >50% of normal.
Beskrivning

creatinine clearance

Datatyp

boolean

Alias
UMLS CUI [1]
C0373595
liver - the total serum bilirubin < 2.5 mg/dl; alt <2 x upper limit of normal.
Beskrivning

total serum bilirubin

Datatyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201836
lung - patients must have no significant obstructive airways disease or resting hypoxemia (po2 <80), and must have acceptable diffusion capacity (dlco > 50% of predicted).
Beskrivning

Lung Diseases, Obstructive | Hypoxemia | Diffusion capacity of lung, function

Datatyp

boolean

Alias
UMLS CUI [1]
C0600260
UMLS CUI [2]
C0700292
UMLS CUI [3]
C0231971
central nervous system (cns): patients must be free of active or ongoing ischemic or degenerative cns disease and no active or resistant cns leukemia.
Beskrivning

ischemic or degenerative cns disease and no cns leukemia

Datatyp

boolean

Alias
UMLS CUI [1]
C0917798
UMLS CUI [2]
C0270715
UMLS CUI [3]
C1332884
Tillbaka till toppen

Similar models

Eligibility Leukemia NCT00630565

1 Formulär
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00630565
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Child; Age | Whole-Body Irradiation | busulfan/cyclophosphamide; Preparative Regimen | prior radiation therapy
Item
children under the age of two are eligible for this protocol, but will not receive total body irradiation. instead, children under the age of two will receive busulfan/cyclophosphamide (bu/cy) conditioning as the preparative regimen in order to obviate deleterious effects of radiation at this age. patients who cannot receive total body irradiation (tbi) (for example those with prior radiation therapy) will also receive the bu/cy conditioning.
boolean
C0008059 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0043162 (UMLS CUI [2])
C0278611 (UMLS CUI [3,1])
C1882454 (UMLS CUI [3,2])
C0279134 (UMLS CUI [4])
aml
Item
acute myeloid leukemia (aml)
boolean
C0023467 (UMLS CUI [1])
Age | Leukemia, Myelocytic, Acute | Acute myeloid leukemia in remission; Bone Marrow | Harvesting of peripheral blood stem cells | Bone marrow harvesting for transplantation; autologous | Allogeneic bone marrow transplantation; Treatment outcome
Item
all children and adults less than the age of 70 with aml who have achieved a first or second bone marrow remission are eligible for this protocol. patients must undergo peripheral blood stem cell collection or marrow harvest while in remission and must not be expected to have better outcomes with allogeneic transplantation.
boolean
C0001779 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
C0153886 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C0457411 (UMLS CUI [4])
C3248104 (UMLS CUI [5])
C0149615 (UMLS CUI [6,1])
C0085415 (UMLS CUI [6,2])
cytogenetic abnormalities suggesting an improved prognosis, remission
Item
patients with cytogenetic abnormalities suggesting an improved prognosis [t(8:21), t(15;17) and inv(16)] will be eligible for transplantation in first remission.
boolean
C1541330 (UMLS CUI [1,1])
C1514475 (UMLS CUI [1,2])
C0544452 (UMLS CUI [2])
C1504389 (UMLS CUI [3])
Allogeneic bone marrow transplantation | Histocompatibility Testing; Allograft of bone marrow from sibling donor | Age
Item
allogeneic transplant with an hla-identical sibling will be recommended for patients <55 years. if the patient refuses allogeneic transplant, they may still be eligible for this protocol.
boolean
C0149615 (UMLS CUI [1])
C0019633 (UMLS CUI [2,1])
C1960320 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Drug toxicity | Heart Diseases | Lung diseases | Kidney Diseases | Liver diseases | CNS disorder
Item
patients can also be deemed not eligible for transplant because of specific organ toxicity. specifically, patients with pre-existing compromise to the heart, lungs, kidney, cns or liver may be excluded:
boolean
C0013221 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
C0007682 (UMLS CUI [6])
ecog
Item
eastern cooperative oncology group (ecog) performance status: 0 or 1
boolean
C1520224 (UMLS CUI [1])
Heart Diseases | Left ventricular ejection fraction | Echocardiography | Multiple gated acquisition scanning
Item
heart - the patient must be free of symptoms of uncontrolled cardiac disease, and must not have compromised cardiac function detected by echo or by gated cardiac blood flow scan (muga) lvef >45%).
boolean
C0018799 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
C0013516 (UMLS CUI [3])
C0521317 (UMLS CUI [4])
creatinine clearance
Item
kidney - the patient must have a corrected creatinine clearance >50% of normal.
boolean
C0373595 (UMLS CUI [1])
total serum bilirubin
Item
liver - the total serum bilirubin < 2.5 mg/dl; alt <2 x upper limit of normal.
boolean
C1278039 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Lung Diseases, Obstructive | Hypoxemia | Diffusion capacity of lung, function
Item
lung - patients must have no significant obstructive airways disease or resting hypoxemia (po2 <80), and must have acceptable diffusion capacity (dlco > 50% of predicted).
boolean
C0600260 (UMLS CUI [1])
C0700292 (UMLS CUI [2])
C0231971 (UMLS CUI [3])
ischemic or degenerative cns disease and no cns leukemia
Item
central nervous system (cns): patients must be free of active or ongoing ischemic or degenerative cns disease and no active or resistant cns leukemia.
boolean
C0917798 (UMLS CUI [1])
C0270715 (UMLS CUI [2])
C1332884 (UMLS CUI [3])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial